Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata

LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients MUMBAI, India and PRINCETON, N.J., July 14, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with...

Read More